TORONTO, May 3, 2016 /CNW/ - Gerald Solensky, Jr., Chief Executive Officer, Zomedica Pharmaceuticals Corp. (ZOM) joined Richard Rohan, VP, Corporate Sales, TMX Equity Transfer & Trust Company to open the market. Zomedica is a veterinary pharmaceutical company based in Ann Arbor, Michigan, targeting health and wellness solutions for companion animals (canine, feline and equine) through an approach that focuses on the needs of clinical veterinarians. Zomedica Pharmaceuticals Corp. commenced trading on TSX Venture Exchange on May 2, 2016.
SOURCE Toronto Stock Exchange
Image with caption: "Gerald Solensky, Jr., Chief Executive Officer, Zomedica Pharmaceuticals Corp. (ZOM) joined Richard Rohan, VP, Corporate Sales, TMX Equity Transfer & Trust Company to open the market. Zomedica is a veterinary pharmaceutical company based in Ann Arbor, Michigan, targeting health and wellness solutions for companion animals (canine, feline and equine) through an approach that focuses on the needs of clinical veterinarians. Zomedica Pharmaceuticals Corp. commenced trading on TSX Venture Exchange on May 2, 2016. (CNW Group/TMX Group Limited) (CNW Group/Toronto Stock Exchange)". Image available at: http://photos.newswire.ca/images/download/20160503_C9163_PHOTO_EN_44739.jpg
Share this article